End stage liver disease in a 13-year old secondary to hepatitis C and hemochromatosis

American Journal of Gastroenterology

Volumn 91, Issue 7, 1996, Pages 1427-1429

  Miller, Mark ^a   Crippin, Jeffrey S ^a,b   Klintmalm, Göran ^a  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^b Liver Service   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; CASE REPORT; GENETIC DISORDER; HEMOCHROMATOSIS; HEPATITIS C; HUMAN; HUMAN TISSUE; JAUNDICE; LIVER FIBROSIS; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL;

ADOLESCENT; CHRONIC DISEASE; DISEASE PROGRESSION; HEMOCHROMATOSIS; HEPATITIS C; HUMANS; LIVER; LIVER FAILURE; LIVER TRANSPLANTATION; MALE;

EID: 0030057821     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. DiBisceglie AM, Axiotis CA, Hoofnagle JH, et al. Measurements of iron status in patients with chronic hepatitis. Gastroenterology 1992; 102:2108-13.
2. Barry M, Sherlock S. Measurement of liver iron concentration in needle-biopsy specimens. Lancet 1971;1:100-3.
3. Wright TL, Combs C, Kim M, et al. Interferon-alpha therapy for hepatitis C virus infection after liver transplantation. Hepatology 1994; 20:773-9.
4. Kilpe VE, Krakauer H, Wren RE. An analysis of liver transplant experience from 37 transplant centers as reported to Medicare. Transplantation 1993;56:554-61.
5. Bassett ML, Halliday JW, Powell LW. Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology 1986;6:24-9.
6. Nichols GM, Bacon BR. Iron metabolism and disorders of iron overload. In: Kaplowitz N, ed. Liver and biliary diseases. Williams & Wilkins, 1992:309-21.
7. Corwin Q, Edwards MD, Cartwright MD, et al. Homozygosity for hemochromatosis: Clinical manifestations. Ann Intern Med 1980;93: 519-25.
8. DeBont B, Walker AC, Carter RF, et al. Idiopathic hemochromatosis presenting as acute hepatitis. J Pediatr 1987;110:431-4.
9. Lampertico P, Rumi M, Romeo R, et al. A multicenter randomized controlled trial of recombinant interferon-alpha 2b in patients with acute transfusion-associated hepatitis C. Hepatology 1994;19:19-22.
10. Piperno A, D'Alba R, Fracanzani AL, et al. Liver damage in Italian patients with hereditary hemochromatosis is highly influenced by hepatitis B and C virus infection. J Hepatol 1992;16:364-8.
11. Caraceni P, Fagiuoli S, Van Thiel DH. Iron reduction therapy: Simply camouflage, or a real weapon? Am J Gastroenterol 1994;89:970-3.
12. Kemp JD. The role of iron and iron-binding proteins in lymphocyte physiology and pathology. J Clin Immunol 1993;13:81-92.
13. Litwin CM, Calderwood SB. Role of iron in regulation of virulence genes. Clin Microbiol Rev 1993;6:137-8.
14. Hayashi M, Takikawa T, Nishimura N, et al. Improvement of serum aminotransferase levels following phlebotomy in patients with chronic active hepatitis C and excess hepatic iron. Am J Gastroenterol 1994; 89:986-8.
15. Van Thiel DH, Friedlander L, Fagiuoli S, et al. Response to interferon alpha therapy is influenced by the iron content of the liver. J Hepatol 1994;20:410-5.
16. Olynyk JK, Reddy KR, DiBisceglie AM, et al. Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C. Gastroenterology 1995;108:1104-9.
17. Bacon BR, Fried MW, DiBisceglie AM. A 39-year-old man with chronic hepatitis, elevated serum ferritin values and a family history of hemochromatosis. Semin Liv Dis 1993;13:101-5.
18. Bryan C. The immunogenetics of hereditary hemochromatosis. Am J Med Sci 1991;301:47-9.
19. Wright TL, Donegan E, Hsu H, et al. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology 1992; 103:317-22.
20. Powell L. Does transplantation of the liver cure genetic hemochromatosis? J Hepatol 1992;16:259-61.